Prevention of malnutrition in peritoneal dialysis patients

被引:0
作者
Lobbedez, T [1 ]
Pujo, M [1 ]
El Haggan, W [1 ]
de Ligny, BH [1 ]
Levaltier, B [1 ]
Ryckelynck, JP [1 ]
机构
[1] CHU Clemenceau, Serv Nephrol Dialyse & Transplantat Renale, F-14033 Caen, France
来源
NEPHROLOGIE | 2003年 / 24卷 / 07期
关键词
nutrition; peritoneal dialysis; inflammation;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Malnutrition is a frequent and serious problem for patients treated by peritoneal dialysis. Patients' survival depends on their nutritional status at the,initiation of the dialysis treatment. Main malnutrition factors are inflammation, insufficient dialysis dose, peritoneal glucidic absorption and protein loss within the dialysate. These patients show a relationship between malnutrition, inflammation and cardiovascular diseases. To prevent malnutrition, it is necessary to reduce inflammation by improving dialysis solutions biocompatibility and optimising the sodium regulation. The peritoneal membrane exposure to both glucose and its degradation products must also be reduced. In order to restrict protein losses, especially when peritoneal hyper permeability occurred, dialysis solutions containing amino acids can be used. Early dialysis treatment and a progressive increase of the dialysis dose corresponding to the decrease of the residual renal function can also be recommended.
引用
收藏
页码:387 / 389
页数:3
相关论文
共 26 条
  • [1] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
    Albert, MA
    Danielson, E
    Rifai, N
    Ridker, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70
  • [2] Effect of fluid and sodium removal on mortality in peritoneal dialysis patients
    Ates, K
    Nergizoglu, G
    Keven, K
    Sen, A
    Kutlay, S
    Ertürk, S
    Duman, N
    Karatan, O
    Ertug, AE
    [J]. KIDNEY INTERNATIONAL, 2001, 60 (02) : 767 - 776
  • [3] Bergström J, 1999, PERITON DIALYSIS INT, V19, pS309
  • [4] Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines
    Bolton, CH
    Downs, LG
    Victory, JGG
    Dwight, JF
    Tomson, CRV
    Mackness, MI
    Pinkney, JH
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (06) : 1189 - 1197
  • [5] Carrasco AM, 2001, PERITON DIALYSIS INT, V21, P546
  • [6] Chung SH, 2000, PERITON DIALYSIS INT, V20, pS57
  • [7] An evidence-based approach to earlier initiation of dialysis
    Churchill, DN
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (06) : 899 - 906
  • [8] Churchill DN, 1996, J AM SOC NEPHROL, V7, P198
  • [9] Cooker LA, 2001, PERITON DIALYSIS INT, V21, pS102
  • [10] Biocompatibility of icodextrin
    Cooker, LA
    Holmes, CJ
    Hoff, CM
    [J]. KIDNEY INTERNATIONAL, 2002, 62 : S34 - S45